Brief: DermTech Announces Contract With Hawaii Blues Plan For The Foundational Assay Of Its Dermtech Melanoma Test (DMT)
07/06/2023 13:28
June 7 (Reuters) - DermTech Inc DMTKW.PK :
* DERMTECH ANNOUNCES CONTRACT WITH HAWAII BLUES PLAN FOR THE
FOUNDATIONAL ASSAY OF ITS DERMTECH MELANOMA TEST (DMT)
Source text for Eikon: ID:nBwbPVwppa
Further company coverage: DMTKW.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DermTech
See all newsBrief: Dermtech Announces Completion Of Workforce Reduction And One-Time Charge To Be Incurred In Q2
DermTech shares sink after filing for bankruptcy
Brief: Dermtech Files For Voluntary Chapter 11 Protection
Brief: Dermtech Inc Files For Chapter 11 Bankruptcy- Court Filing
Brief: DermTech To Explore Strategic Alternatives, Implement Restructuring Plan